159 related articles for article (PubMed ID: 12269833)
1. Polycyclic aromatic hydrocarbon o-quinones inhibit the activity of the catalytic fragment of protein kinase C.
Yu D; Kazanietz MG; Harvey RG; Penning TM
Biochemistry; 2002 Oct; 41(39):11888-94. PubMed ID: 12269833
[TBL] [Abstract][Full Text] [Related]
2. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
[TBL] [Abstract][Full Text] [Related]
3. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells.
Palackal NT; Lee SH; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2002 Jul; 277(27):24799-808. PubMed ID: 11978787
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation.
Palackal NT; Burczynski ME; Harvey RG; Penning TM
Biochemistry; 2001 Sep; 40(36):10901-10. PubMed ID: 11535067
[TBL] [Abstract][Full Text] [Related]
5. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
Burczynski ME; Lin HK; Penning TM
Cancer Res; 1999 Feb; 59(3):607-14. PubMed ID: 9973208
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione.
Burczynski ME; Harvey RG; Penning TM
Biochemistry; 1998 May; 37(19):6781-90. PubMed ID: 9578563
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53.
Yu D; Berlin JA; Penning TM; Field J
Chem Res Toxicol; 2002 Jun; 15(6):832-42. PubMed ID: 12067251
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells.
Park JH; Mangal D; Tacka KA; Quinn AM; Harvey RG; Blair IA; Penning TM
Proc Natl Acad Sci U S A; 2008 May; 105(19):6846-51. PubMed ID: 18474869
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells.
Flowers-Geary L; Harvey RG; Penning TM
Chem Res Toxicol; 1993; 6(3):252-60. PubMed ID: 7686407
[TBL] [Abstract][Full Text] [Related]
10. Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling.
Park JH; Gopishetty S; Szewczuk LM; Troxel AB; Harvey RG; Penning TM
Chem Res Toxicol; 2005 Jun; 18(6):1026-37. PubMed ID: 15962938
[TBL] [Abstract][Full Text] [Related]
11. Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism.
Penning TM
Chem Biol Interact; 1993 Oct; 89(1):1-34. PubMed ID: 8221964
[TBL] [Abstract][Full Text] [Related]
12. The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance.
Park JH; Gelhaus S; Vedantam S; Oliva AL; Batra A; Blair IA; Troxel AB; Field J; Penning TM
Chem Res Toxicol; 2008 May; 21(5):1039-49. PubMed ID: 18489080
[TBL] [Abstract][Full Text] [Related]
13. Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol.
Abedin Z; Sen S; Field J
Chem Res Toxicol; 2012 Jan; 25(1):113-21. PubMed ID: 22053912
[TBL] [Abstract][Full Text] [Related]
14. Detoxication of structurally diverse polycyclic aromatic hydrocarbon (PAH) o-quinones by human recombinant catechol-O-methyltransferase (COMT) via O-methylation of PAH catechols.
Zhang L; Jin Y; Chen M; Huang M; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2011 Jul; 286(29):25644-54. PubMed ID: 21622560
[TBL] [Abstract][Full Text] [Related]
15. Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species.
Park JH; Troxel AB; Harvey RG; Penning TM
Chem Res Toxicol; 2006 May; 19(5):719-28. PubMed ID: 16696575
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of rat dihydrodiol dehydrogenase (AKR1C9) in human breast MCF-7 cells results in the formation of PAH-o-quinones and enzyme mediated cell death.
Tsuruda L; Hou Yt ; Penning TM
Chem Res Toxicol; 2001 Jul; 14(7):856-62. PubMed ID: 11453732
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of polycyclic aromatic hydrocarbon trans-dihydrodiols by ubiquitously expressed aldehyde reductase (AKR1A1).
Palackal NT; Burczynski ME; Harvey RG; Penning TM
Chem Biol Interact; 2001 Jan; 130-132(1-3):815-24. PubMed ID: 11306097
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon ortho-quinones produced by dihydrodiol dehydrogenase.
Flowers-Geary L; Bleczinki W; Harvey RG; Penning TM
Chem Biol Interact; 1996 Jan; 99(1-3):55-72. PubMed ID: 8620579
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.
Quinn AM; Harvey RG; Penning TM
Chem Res Toxicol; 2008 Nov; 21(11):2207-15. PubMed ID: 18788756
[TBL] [Abstract][Full Text] [Related]
20. Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.
Penning TM
Chem Res Toxicol; 2014 Nov; 27(11):1901-17. PubMed ID: 25279998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
